Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.
Journal: Lancet (London, England)
Published: April 25, 2022
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 09, 2022
Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 12, 2019
Showing 1-3 of 3
Last Updated: 09/26/2026